Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a new animal drug application filed by Novartis Animal Health US, Inc. that provides for the veterinary prescription use of cyclosporine by oral capsule for the control of atopic dermatitis in dogs. To view this final rule, click here.